Other
Other
Moderna Other decreased by 16.7% to $30.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.0%, from $40.00M to $30.00M. Over 2 years (FY 2023 to FY 2025), Other shows an upward trend with a 30.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2023
Last reportedQ1 2026May 1, 2026
How to read this metric
Large, unexpected increases should be investigated as they may represent hidden long-term risks or accounting adjustments.
Detailed definition
This category includes miscellaneous long-term obligations that are not classified under specific debt or pension catego...
Peer comparison
Varies significantly by industry and specific accounting policies.
Metric ID:
other_other_sundry_liabilities_noncurrentHistorical Data
8 periods
| Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $21.00M | $35.00M | $36.00M | $40.00M | $39.00M | $42.00M | $36.00M | $30.00M |
| QoQ Change | — | +66.7% | +2.9% | +11.1% | -2.5% | +7.7% | -14.3% | -16.7% |
| YoY Change | — | — | +71.4% | — | — | +20.0% | +0.0% | -25.0% |
Range$21.00M – $42.00M
CAGR+22.6%
Avg YoY Growth+16.6%
Median YoY Growth+10.0%
Current Streak2 quarters decline
Other at Other Companies
Frequently Asked Questions
- What is Moderna's other?
- Moderna (MRNA) reported other of $30.00M in Q1 2026.
- How has Moderna's other changed year-over-year?
- Moderna's other decreased by 25.0% year-over-year, from $40.00M to $30.00M.
- What is the long-term trend for Moderna's other?
- Over 2 years (2023 to 2025), Moderna's other has grown at a 30.9% compound annual growth rate (CAGR), from $21.00M to $36.00M.
- What does other mean?
- Miscellaneous long-term debts or obligations not classified elsewhere.